63E Stock Overview
A medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
Onward Medical N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €4.81 |
| 52 Week High | €6.34 |
| 52 Week Low | €2.04 |
| Beta | 0.80 |
| 1 Month Change | -5.69% |
| 3 Month Change | n/a |
| 1 Year Change | 57.70% |
| 3 Year Change | -42.40% |
| 5 Year Change | n/a |
| Change since IPO | -61.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| 63E | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -3.0% | -2.6% |
| 1Y | 57.7% | -7.8% | 7.1% |
Return vs Industry: 63E exceeded the German Medical Equipment industry which returned -6.9% over the past year.
Return vs Market: 63E exceeded the German Market which returned 8% over the past year.
Price Volatility
| 63E volatility | |
|---|---|
| 63E Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.6% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 63E's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine 63E's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 99 | Dave Marver | www.onwd.com |
Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Onward Medical N.V. Fundamentals Summary
| 63E fundamental statistics | |
|---|---|
| Market cap | €211.54m |
| Earnings (TTM) | -€35.15m |
| Revenue (TTM) | n/a |
-1,125x
P/S Ratio-6.0x
P/E RatioIs 63E overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 63E income statement (TTM) | |
|---|---|
| Revenue | -€188.00k |
| Cost of Revenue | €13.44m |
| Gross Profit | -€13.63m |
| Other Expenses | €21.52m |
| Earnings | -€35.15m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.79 |
| Gross Margin | 7,250.53% |
| Net Profit Margin | 18,697.34% |
| Debt/Equity Ratio | 87.3% |
How did 63E perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 12:49 |
| End of Day Share Price | 2024/12/09 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Onward Medical N.V. is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dylan van Haaften | Bryan Garnier & Co |
| Maria Vara Fernández | Bryan Garnier & Co |
| David Seynnaeve | Degroof Petercam |